var title_f31_5_31824="Optic neuritis fundus";
var content_f31_5_31824=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F50320&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F50320&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Optic neuritis fundus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 341px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Papillitis: Note the absence of hemorrhages and exudates in the setting of optic neuritis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31824=[""].join("\n");
var outline_f31_5_31824=null;
var title_f31_5_31825="Spiration intrabronchial valve";
var content_f31_5_31825=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 593px\">",
"   <div class=\"ttl\">",
"    Intrabronchial valve appearance and nomenclature",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 573px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Wood DE, McKenna RJ, Yusen RD, et al. A multicenter trial of an intrabronchial valve for treatment of severe emphysema. J Thorac Cardiovasc Surg 2007; 133:65. Illustration reproduced with permission from Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31825=[""].join("\n");
var outline_f31_5_31825=null;
var title_f31_5_31826="Guanidine: Drug information";
var content_f31_5_31826=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Guanidine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?3/2/3108?source=see_link\">",
"    see \"Guanidine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F178212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Cholinergic Agonist",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F178210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Eaton-Lambert syndrome:",
"     </b>",
"     Oral: Initial: 10-15 mg/kg/day in 3-4 divided doses, gradually increase to 35 mg/kg/day, or up to development of side effects",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F178211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15682684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15682685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F178206\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 125 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F178201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F178207\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reduction of the symptoms of muscle weakness associated with the myasthenic syndrome of Eaton-Lambert, not for myasthenia gravis",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F178215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Guanidine may be confused with guanFACINE",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F15669286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiovascular: Atrial fibrillation, flushing, hypotension, palpitation, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Ataxia, confusion, emotional lability, fever, hallucination, irritability, jitteriness, lightheadedness, mood changes, nervousness, psychotic state",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dermatologic: Bruising, dry skin, folliculitis, petechiae, purpura, rash, skin eruptions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Abdominal cramps, anorexia, diarrhea, gastric irritation, nausea, sore throat, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hematologic: Anemia, bone-marrow suppression, leukopenia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hepatic: Abnormal liver function tests",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular &amp; skeletal: Paresthesia, trembling, tremor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Renal: Creatinine increased, interstitial nephritis (acute or chronic), renal tubular necrosis, uremia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Miscellaneous: Cold extremities, diaphoresis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F15669282\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to guanidine or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F15669283\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Bone marrow suppression: Dose-related, fatal bone marrow suppression had been reported with use. Avoid concurrent use with medications known to suppress bone marrow. Monitor closely; discontinue use if bone marrow suppression is suspected.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299429\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6220733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors: May enhance the adverse/toxic effect of Cholinergic Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: May enhance the adverse/toxic effect of Cholinergic Agonists. Of particular concern are the potential for cardiac conduction abnormalities and bronchoconstriction. Management: Administer these agents in combination with caution, and monitor for conduction disturbances.  Avoid methacholine with any beta blocker due to the potential for additive bronchoconstriction.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13763486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F13763487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excreted in breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323177\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Guanidine HCl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     125 mg (100): $25.32",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F15669293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC with differential (baseline and frequently thereafter); creatinine, BUN, urinalysis",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8967 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-197.136.42.3-E002DE631A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31826=[""].join("\n");
var outline_f31_5_31826=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178212\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178210\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178211\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682684\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682685\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178206\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178201\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178207\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178215\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15669286\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15669282\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15669283\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299429\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6220733\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13763486\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13763487\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323177\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15669293\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8967\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8967|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?3/2/3108?source=related_link\">",
"      Guanidine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_5_31827="Abdominal aortic aneurysm with bleb";
var content_f31_5_31827=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F87326&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F87326&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 610px\">",
"   <div class=\"ttl\">",
"    Abdominal aortic aneurysm with bleb",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 590px; height: 394px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An unstable large infrarenal aortic aneurysm in this 90-year-old female shows a focal bulge in the left lateral wall of the aneurysm (white arrow) suggesting an impending rupture.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31827=[""].join("\n");
var outline_f31_5_31827=null;
var title_f31_5_31828="Hands in RA PI";
var content_f31_5_31828=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F70434&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F70434&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rheumatoid arthritis in the hands",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 446px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    These photos show the hands of a 40-year-old woman who was diagnosed with rheumatoid arthritis as a child.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Patrick J Venables, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31828=[""].join("\n");
var outline_f31_5_31828=null;
var title_f31_5_31829="Fetal intralobar sequestration";
var content_f31_5_31829=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F51114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F51114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 475px\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound and magnetic resonance images of fetal intralobar sequestration at 29 weeks of gestation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 455px; height: 478px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Axial ultrasound demonstrates a large echogenic mass in the right lower lobe. (D) Doppler examination shows a dominant vessel originating from the thoracic aorta and coursing to the mass. (B) and (C) T2w magnetic resonance images demonstrate a large echogenic mass in the right lower lobe with mild mediastinal shift to the left; (B) axial and (C) coronal views. CVR is 0.8, indicating a low risk for hydrops.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dorothy I Bulas, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31829=[""].join("\n");
var outline_f31_5_31829=null;
var title_f31_5_31830="Endocarditis caused by Bartonella";
var content_f31_5_31830=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Endocarditis caused by Bartonella",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/5/31830/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/5/31830/contributors\">",
"     David H Spach, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/5/31830/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/5/31830/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/5/31830/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/5/31830/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/5/31830/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bartonella was first described as a cause of endocarditis in two separate reports in 1993 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/1,2\">",
"     1,2",
"    </a>",
"    ] and subsequently has become appreciated as a significant cause of \"culture-negative\" endocarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/3-11\">",
"     3-11",
"    </a>",
"    ]. A group of French investigators have generated the majority of reports on endocarditis caused by Bartonella, including several multicenter international studies that involved patients from France, England, and Canada [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/3,11\">",
"     3,11",
"    </a>",
"    ]. Six Bartonella species have been reported to cause infective endocarditis in humans: B. quintana, B. henselae, B. elizabethae, B. vinsonii, B. koehlerae, and B. alsatica [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/3,12,13\">",
"     3,12,13",
"    </a>",
"    ]. More than 95 percent of the cases, however, have involved either B. quintana or B. henselae.",
"   </p>",
"   <p>",
"    Bartonella endocarditis will be reviewed here. Other aspects of Bartonella infection are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/47/23289?source=see_link\">",
"     \"Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/63/8182?source=see_link\">",
"     \"Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36583?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of Bartonella quintana infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/56/26503?source=see_link\">",
"     \"Bartonellosis: Oroya fever and verruga peruana\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiologic features of the patients documented to have Bartonella endocarditis have varied considerably. Most reports have involved adult patients, although several cases have been described in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/10,14\">",
"     10,14",
"    </a>",
"    ]. Overall, more than 70 percent of cases have involved men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Available data suggest that homelessness, alcoholism, and infestation with body lice are associated with B. quintana endocarditis, whereas contact with cats and previous valvular disease serve as the major risk factors for B. henselae endocarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/3,4,11,15\">",
"     3,4,11,15",
"    </a>",
"    ]. Case reports have described Bartonella endocarditis in HIV-infected patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with Bartonella endocarditis have clinical manifestations similar to other patients with subacute bacterial endocarditis (as described by the Duke criteria) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/23/31094?source=see_link\">",
"     \"Infective endocarditis: Historical and Duke criteria\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Affected patients typically present with subacute, nonspecific symptoms including fever, fatigue, weakness, and weight loss. Most also have evidence of a murmur on cardiac auscultation. Approximately 60 percent of patients with Bartonella endocarditis have involvement of the aortic valve [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/11\">",
"     11",
"    </a>",
"    ]; the reason for the apparent predilection to infect the aortic valve is unknown.",
"   </p>",
"   <p>",
"    Several cases have involved multiple valves, usually either the aortic and mitral or the aortic and tricuspid valves. Isolated right-sided endocarditis appears to occur infrequently [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/11,17\">",
"     11,17",
"    </a>",
"    ]. In the largest series, approximately 55 percent of the patients had evidence of preexisting cardiac valvular disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/3\">",
"     3",
"    </a>",
"    ]. Of the reported cases, approximately 60 percent of patients have undergone cardiac valvular surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/3,4,15\">",
"     3,4,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although most cases involve native valves, case reports of prosthetic valve endocarditis describe an aggressive disease characterized by valvular perforation or rapid progression of mitral stenosis and heart failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because patients with Bartonella endocarditis have blood cultures that require prolonged incubation before they turn positive (if they turn positive at all), patients are often initially diagnosed as having culture-negative endocarditis. Indeed, in the multicenter international studies, only approximately 25 percent had positive blood cultures at any time in their clinical course [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/3\">",
"     3",
"    </a>",
"    ]. Thus, the diagnosis of Bartonella endocarditis often requires modalities other than blood culture for identifying the organism.",
"   </p>",
"   <p>",
"    A retrospective study of 348 patients with suspected blood culture-negative endocarditis utilized serologic tests and direct PCR from valve specimens (when available) along with culture and identified 99 (28 percent) with Bartonella spp. as the etiologic agent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/53/34646?source=see_link\">",
"     \"Culture-negative endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most important first step in diagnosing Bartonella endocarditis is to consider the organism in a patient with clinical and echocardiographic findings that suggest endocarditis. Specific laboratory evidence of Bartonella infection can be obtained from a combination of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Positive blood culture",
"     </li>",
"     <li>",
"      Positive serologic titer (with high titer)",
"     </li>",
"     <li>",
"      Characteristic Warthin-Starry staining of cardiac valvular tissue",
"     </li>",
"     <li>",
"      Positive polymerase chain reaction (PCR) on cardiac valvular tissue using a probe specific for Bartonella.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Echocardiography shows valvular vegetations in approximately 90 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/11\">",
"     11",
"    </a>",
"    ]. These vegetations, however, do not appear to have unique or distinguishing features.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bartonella species are fastidious gram-negative bacteria that require specific laboratory conditions for optimal growth. Preferably, blood culture samples should be incubated in pediatric or adult isolator tubes (Wampole, Cranbury, NJ), or in blood tubes containing EDTA. Bartonella species have occasionally been isolated from BACTEC bottles.",
"   </p>",
"   <p>",
"    Plating samples onto either chocolate agar or heart infusion agar supplemented with 5 percent rabbit blood enhances isolation of organisms from subcultures. Optimally, the microbiology laboratory should use fresh agar plates and incubate them in 5 percent CO2 at 35 to 37&ordm;C for a minimum of 21 days. Isolation of Bartonella from cardiac valvular tissue samples has a very low yield, but if attempted, tissue homogenates should be directly plated onto agar and cocultivated with a bovine endothelial cell monolayer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac valvular tissue stained with hematoxylin and eosin characteristically shows mildly inflamed connective tissue with focal granulation tissue reaction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/4\">",
"     4",
"    </a>",
"    ]. Warthin-Starry silver staining of these aggregates, if positive, reveals masses of small, dark-staining bacteria. When electron microscopy is performed, pleomorphic bacilli are seen predominantly located intracellularly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/3\">",
"     3",
"    </a>",
"    ]. In one study of 15 patients with confirmed Bartonella endocarditis, the cardiac valve pathology showed more fibrotic and calcified changes, less vascularization, and less extensive vegetations; these features suggest chronic infection when compared with cases of infective endocarditis caused by other pathogens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/22\">",
"     22",
"    </a>",
"    ]. In addition, approximately 11 (85 percent) of 13 had a positive Warthin-Starry stain of the valve tissue and 10 (77 percent) of the 13 had a positive Bartonella immunohistologic test.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indirect immunofluorescence assay (IFA) and enzyme-linked immunosorbent assay (ELISA) are the two most commonly used serologic methods for Bartonella infections. In the international series, all but one patient with Bartonella endocarditis had titers &ge;1:1600 using a microimmunofluorescence test; the positive predictive value of the test was 0.88 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cross-reactions can occur between Bartonella and Chlamydia sp. In the international series, nine patients previously thought to have Chlamydia endocarditis were reclassified as Bartonella endocarditis based on cross-adsorption studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/3\">",
"     3",
"    </a>",
"    ]. The process of cross-adsorption consists of incubating patient serum with the bacteria suspected of causing cross-reaction in the serologic test. The adsorption process removes antibodies of the bacterium that caused serologic cross-reaction, but the antibodies to the organism causing the disease remain. When tested, adsorption with Bartonella led to a negative serology compared to adsorption with Chlamydia, which removed Chlamydia but not Bartonella reactivity.",
"   </p>",
"   <p>",
"    As with other Bartonella-associated clinical manifestations, significant cross-reactivity occurs at the species level between B. henselae and B. quintana. Clearly defined cut-offs for a positive test do not exist. More recent studies have shown that Western immunoblotting appears to have very high sensitivity and specificity for diagnosing Bartonella endocarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the United States, Bartonella serology testing is commercially available from a number of sites, including Associated Regional University Pathologists (Salt Lake City Utah), Focus Diagnostics (Cypress, California), Mayo Medical Laboratories (Rochester, Minnesota), and Specialty Laboratories, Inc. (Valencia, California).",
"   </p>",
"   <p>",
"    For patients with suspected Bartonella endocarditis, serologic testing can play a supportive role in the appropriate clinical setting, but a convincing diagnosis of Bartonella endocarditis generally requires additional information.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Polymerase chain reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of polymerase chain reaction (PCR)-based tests on cardiac valvular tissue has played an important role in the diagnosis of Bartonella endocarditis. Tissue is frequently available because patients often undergo surgical removal of the infected valve and have negative blood cultures as noted above. The PCR test in current use to detect Bartonella species amplifies a 296 base pair fragment of the 16S ribosomal RNA. Investigators reported positive PCR testing for Bartonella on cardiac valve tissue in more than 95 percent of patients with Bartonella endocarditis in one study, despite the fact that more than 60 percent of these patients had their valves analyzed following the receipt of antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/15\">",
"     15",
"    </a>",
"    ]. A lower sensitivity of PCR (58 percent) has been reported in serum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, PCR can distinguish among the different Bartonella species. Nevertheless, because relatively little data exist with PCR-based tests for Bartonella species, these tests should be considered investigational. Although paraffin-embedded specimens can be used, the yield appears to be greater using fresh valvular tissue. The PCR test on tissue samples is available commercially through multiple laboratories, including Associated Regional University Pathologists, Focus Diagnostics, Mayo Medical Laboratories, and Specialty Laboratories, Inc. In addition, PCR testing of whole blood samples is now commercially available through the same laboratories.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal antibiotic therapy for Bartonella endocarditis is unknown. Evaluation of differing regimens is hampered by two factors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most patients with Bartonella endocarditis have undergone cardiac valvular surgery with removal of the infected valve, making it difficult to assess the role of antibiotics.",
"     </li>",
"     <li>",
"      No consistent regimen has been used to treat the infection because the literature consists of a series of case reports; no randomized trials of treatment for Bartonella endocarditis have been published, nor are they likely to be performed in the near future.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based upon available reports of Bartonella endocarditis and experience with other Bartonella infections, the tetracyclines (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    ) probably are the best choices for long-term therapy. If the patient is intolerant of the tetracyclines, the macrolides (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/57/10138?source=see_link\">",
"     clarithromycin",
"    </a>",
"    ) could be used as an alternative treatment. However, since these two classes of antibiotics have static and not cidal activity, a cidal antibiotic, such as an aminoglycoside, should be added in the first several weeks of therapy.",
"   </p>",
"   <p>",
"    In contrast,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    , penicillins, and cephalosporins (other than third generation cephalosporins) do not have reliable activity against Bartonella and are",
"    <strong>",
"     not",
"    </strong>",
"    recommended.",
"   </p>",
"   <p>",
"    Patients with Bartonella endocarditis usually have a delayed diagnosis because of the prolonged time required for blood cultures to turn positive. Thus, they frequently receive \"culture-negative\" endocarditis regimens.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"     Ceftriaxone",
"    </a>",
"    has become the recommended drug of choice for culture-negative endocarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/25\">",
"     25",
"    </a>",
"    ]. Ceftriaxone probably has some activity against Bartonella, especially if combined with an aminoglycoside.",
"   </p>",
"   <p>",
"    A benefit from aminoglycoside therapy was suggested in a retrospective analysis of 101 patients with endocarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/11\">",
"     11",
"    </a>",
"    ]. Patients who received a regimen that included at least 14 days of an aminoglycoside had a greater likelihood of achieving full recovery and of surviving the infection than those treated only with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    . In addition, in one study of 20 patients with chronic bacteremia caused by B. quintana, patients were randomized to receive either no treatment or a combination of doxycycline plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    ; in this study bacteremia was eradicated in seven of nine treated patients versus 2 of 11 untreated patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Recommendations",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are insufficient data to make any definitive recommendations for treating Bartonella endocarditis. Because Bartonella has become an important cause of \"culture-negative\" endocarditis, initial therapy for \"culture-negative\" endocarditis should consist of a regimen that has good activity against Bartonella.",
"   </p>",
"   <p>",
"    Recommendations published by an expert panel in 2004 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/27\">",
"     27",
"    </a>",
"    ] were incorporated into the 2005 American Heart Association guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/28\">",
"     28",
"    </a>",
"    ] and these 2005 guidelines recommend treating \"culture-negative\" endocarditis due to suspected Bartonella infection with:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"       Ceftriaxone",
"      </a>",
"      (2 gm",
"      <span class=\"nowrap\">",
"       IV/IM",
"      </span>",
"      once daily for six weeks)",
"      <strong>",
"       plus",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"       Gentamicin",
"      </a>",
"      (1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV every eight hours for 14 days; gentamicin dosage should be adjusted to achieve peak serum concentration of 3 to 4",
"      <span class=\"nowrap\">",
"       microgram/mL",
"      </span>",
"      and trough serum concentration of &lt;1",
"      <span class=\"nowrap\">",
"       microgram/mL)",
"      </span>",
"     </li>",
"     <li>",
"      With or without",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      (100 mg PO or IV twice daily for six weeks)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If Bartonella is proven, the guidelines recommend treating with a regimen consisting of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    (100 mg",
"    <span class=\"nowrap\">",
"     IV/PO",
"    </span>",
"    twice a day for six weeks) plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    (1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV every eight hours for 14 days) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31830/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. If the patient cannot receive gentamicin, then",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    (300 mg per day",
"    <span class=\"nowrap\">",
"     IV/PO",
"    </span>",
"    twice a day) should replace the gentamicin.",
"   </p>",
"   <p>",
"    The optimal duration of therapy is not known. Although the guidelines recommend a total of six weeks of therapy, we recommend extending",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    therapy orally for three to six months, due to the severity of Bartonella endocarditis, the lack of treatment duration data, and the very low cost of oral doxycycline. In addition, we recommend that patients who cannot tolerate doxycycline receive a macrolide, preferably",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    (500 mg",
"    <span class=\"nowrap\">",
"     IV/PO",
"    </span>",
"    once daily for a total of three to six months). Those patients who undergo valvular surgery and have all affected cardiac tissue removed can be treated with six weeks of therapy post surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Six Bartonella species have been reported to cause infective endocarditis in humans, although more than 95 percent of the cases have involved either B. quintana or B. henselae. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Available data suggest that homelessness, alcoholism, and infestation with body lice are associated with B. quintana endocarditis, whereas contact with cats and previous valvular disease serve as the major risk factors for B. henselae endocarditis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with Bartonella endocarditis have clinical manifestations similar to other patients with subacute bacterial endocarditis such as fever, fatigue, weakness, and weight loss. Most also have evidence of a murmur on cardiac auscultation. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bartonella species are fastidious gram-negative bacteria that require specific laboratory conditions for optimal growth. Cultures are positive in only a minority of patients. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Culture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Histopathology of cardiac valvular tissue stained with Warthin-Starry silver staining may demonstrate masses of small, dark-staining bacteria. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Histopathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Indirect immunofluorescence assay (IFA) and enzyme-linked immunosorbent assay (ELISA) are the two most commonly used serologic methods for Bartonella infections, and most patients with Bartonella endocarditis have high titer-positive tests. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Serology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The use of polymerase chain reaction (PCR)-based tests on cardiac valvular tissue shows promise, but data are limited. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Polymerase chain reaction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The optimal therapy for Bartonella endocarditis is unknown. For culture-negative endocarditis with suspected Bartonella infection, we recommend",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      (2 gm",
"      <span class=\"nowrap\">",
"       IV/IM",
"      </span>",
"      once daily for six weeks) plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      (1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV every eight hours for 14 days) plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      (100 mg PO or IV twice daily for six weeks). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If Bartonella is proven, we recommend treatment with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      (100 mg",
"      <span class=\"nowrap\">",
"       IV/PO",
"      </span>",
"      twice a day for a minimum of six weeks) plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      (1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV every eight hours for 14 days). If the patient cannot receive gentamicin, then",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      (300 mg per day",
"      <span class=\"nowrap\">",
"       IV/PO",
"      </span>",
"      twice a day) should be used in its place. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Therapy'",
"      </a>",
"      above.) Given the lack of treatment duration data, the severity of Bartonella endocarditis, and the low cost of oral doxycycline, we favor an extended course of doxycycline monotherapy for a total of three to six months following combination therapy.",
"     </li>",
"     <li>",
"      The optimal duration of therapy for suspected or confirmed Bartonella endocarditis is not known. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/1\">",
"      Spach DH, Callis KP, Paauw DS, et al. Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus. J Clin Microbiol 1993; 31:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/2\">",
"      Daly JS, Worthington MG, Brenner DJ, et al. Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis. J Clin Microbiol 1993; 31:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/3\">",
"      Raoult D, Fournier PE, Drancourt M, et al. Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med 1996; 125:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/4\">",
"      Spach DH, Kanter AS, Daniels NA, et al. Bartonella (Rochalimaea) species as a cause of apparent \"culture-negative\" endocarditis. Clin Infect Dis 1995; 20:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/5\">",
"      Holmes AH, Greenough TC, Balady GJ, et al. Bartonella henselae endocarditis in an immunocompetent adult. Clin Infect Dis 1995; 21:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/6\">",
"      Drancourt M, Birtles R, Chaumentin G, et al. New serotype of Bartonella henselae in endocarditis and cat-scratch disease. Lancet 1996; 347:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/7\">",
"      Hadfield TL, Warren R, Kass M, et al. Endocarditis caused by Rochalimaea henselae. Hum Pathol 1993; 24:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/8\">",
"      Jalava J, Kotilainen P, Nikkari S, et al. Use of the polymerase chain reaction and DNA sequencing for detection of Bartonella quintana in the aortic valve of a patient with culture-negative infective endocarditis. Clin Infect Dis 1995; 21:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/9\">",
"      Breathnach AS, Hoare JM, Eykyn SJ. Culture-negative endocarditis: contribution of bartonella infections. Heart 1997; 77:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/10\">",
"      Baorto E, Payne RM, Slater LN, et al. Culture-negative endocarditis caused by Bartonella henselae. J Pediatr 1998; 132:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/11\">",
"      Raoult D, Fournier PE, Vandenesch F, et al. Outcome and treatment of Bartonella endocarditis. Arch Intern Med 2003; 163:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/12\">",
"      Avidor B, Graidy M, Efrat G, et al. Bartonella koehlerae, a new cat-associated agent of culture-negative human endocarditis. J Clin Microbiol 2004; 42:3462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/13\">",
"      Raoult D, Roblot F, Rolain JM, et al. First isolation of Bartonella alsatica from a valve of a patient with endocarditis. J Clin Microbiol 2006; 44:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/14\">",
"      Posfay Barbe K, Jaeggi E, Ninet B, et al. Bartonella quintana endocarditis in a child. N Engl J Med 2000; 342:1841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/15\">",
"      Fournier PE, Lelievre H, Eykyn SJ, et al. Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients. Medicine (Baltimore) 2001; 80:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/16\">",
"      Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/17\">",
"      Bruneel F, D'estanque J, Fournier PE, et al. Isolated right-sided Bartonella quintana endocarditis in an immunocompetent adult. Scand J Infect Dis 1998; 30:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/18\">",
"      Klein JL, Nair SK, Harrison TG, et al. Prosthetic valve endocarditis caused by Bartonella quintana. Emerg Infect Dis 2002; 8:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/19\">",
"      Kreisel D, Pasque MK, Damiano RJ Jr, et al. Bartonella species-induced prosthetic valve endocarditis associated with rapid progression of valvular stenosis. J Thorac Cardiovasc Surg 2005; 130:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/20\">",
"      Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore) 2005; 84:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/21\">",
"      Koehler JE, Quinn FD, Berger TG, et al. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med 1992; 327:1625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/22\">",
"      Lepidi H, Fournier PE, Raoult D. Quantitative analysis of valvular lesions during Bartonella endocarditis. Am J Clin Pathol 2000; 114:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/23\">",
"      Houpikian P, Raoult D. Western immunoblotting for Bartonella endocarditis. Clin Diagn Lab Immunol 2003; 10:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/24\">",
"      Zeaiter Z, Fournier PE, Greub G, Raoult D. Diagnosis of Bartonella endocarditis by a real-time nested PCR assay using serum. J Clin Microbiol 2003; 41:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/25\">",
"      Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 1995; 274:1706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/26\">",
"      Foucault C, Raoult D, Brouqui P. Randomized open trial of gentamicin and doxycycline for eradication of Bartonella quintana from blood in patients with chronic bacteremia. Antimicrob Agents Chemother 2003; 47:2204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/27\">",
"      Rolain JM, Brouqui P, Koehler JE, et al. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004; 48:1921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31830/abstract/28\">",
"      Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111:e394.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2145 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-F0C764AA00-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31830=[""].join("\n");
var outline_f31_5_31830=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Culture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Serology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Polymerase chain reaction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/56/26503?source=related_link\">",
"      Bartonellosis: Oroya fever and verruga peruana",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36583?source=related_link\">",
"      Clinical features, diagnosis, and treatment of Bartonella quintana infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/53/34646?source=related_link\">",
"      Culture-negative endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/63/8182?source=related_link\">",
"      Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/23/31094?source=related_link\">",
"      Infective endocarditis: Historical and Duke criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/47/23289?source=related_link\">",
"      Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_5_31831="Imipramine: Pediatric drug information";
var content_f31_5_31831=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Imipramine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?40/41/41624?source=see_link\">",
"    see \"Imipramine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/18/36133?source=see_link\">",
"    see \"Imipramine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F182136\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tofranil-PM&reg;;",
"     </li>",
"     <li>",
"      Tofranil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F182137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Imipramine&reg;;",
"     </li>",
"     <li>",
"      Novo-Pramine;",
"     </li>",
"     <li>",
"      Tofranil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1053361\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidepressant, Tricyclic (Tertiary Amine)",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1053355\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?40/41/41624?source=see_link\">",
"      see \"Imipramine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Depression:",
"     <b>",
"      Note:",
"     </b>",
"     Not FDA approved for the treatment of depression in pediatric patients; controlled clinical trials have not shown tricyclic antidepressants to be superior to placebo for the treatment of depression in children and adolescents (Dopheide, 2006; Wagner, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     1.5 mg/kg/day with dosage increments of 1 mg/kg every 3-4 days to a maximum dose of 5 mg/kg/day in 1-4 divided doses; monitor carefully especially with doses &ge;3.5 mg/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Enuresis: &ge;6 years: Initial: 10-25 mg at bedtime, if inadequate response still seen after 1 week of therapy, increase by 25 mg/day; dose should not exceed 2.5 mg/kg/day or 50 mg at bedtime if 6-12 years of age or 75 mg at bedtime if &ge;12 years of age",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adjunct in the treatment of cancer pain: Initial: 0.2-0.4 mg/kg at bedtime; dose may be increased by 50% every 2-3 days up to 1-3 mg/kg/dose at bedtime",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adolescents: Depression: Initial: 25-50 mg/day; increase gradually; maximum dose: 100 mg/day in single or divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults: Depression:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Outpatients: Initial: 75 mg/day; may increase gradually to 150 mg/day. May be given in divided doses or as a single bedtime dose; maximum: 200 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Inpatients: Initial: 100-150 mg/day; may increase gradually to 200 mg/day; if no response after 2 weeks, may further increase to 250-300 mg/day. May be given in divided doses or as a single bedtime dose; maximum: 300 mg/day.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Following remission, a maintenance dose may be required for a longer period of time; use lowest effective dose; adolescents can usually be maintained at a lower dose; usual adult maintenance dose: 75-150 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F182116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral, as pamoate: 75 mg, 100 mg, 125 mg, 150 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tofranil-PM&reg;: 75 mg, 100 mg, 125 mg, 150 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 10 mg, 25 mg, 50 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tofranil&reg;: 10 mg, 25 mg, 50 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F182101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and as follows, must be dispensed with this medication:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Tofranil&reg;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/ucm089161.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/ucm089161.pdf",
"     </a>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Tofranil-PM&reg;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM326090.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM326090.pdf",
"     </a>",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1053366\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: May administer with food to decrease GI distress. For treatment of enuresis, administer dose 1 hour before bedtime; for early night bedwetters, drug has been shown to be more effective if given earlier and in divided amounts (eg, 25 mg in midafternoon and repeated at bedtime)",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F5978078\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at controlled room temperature at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); dispense in tightly closed container",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1053365\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of various forms of depression, often in conjunction with psychotherapy; enuresis in children; analgesic for certain chronic and neuropathic pain",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F182188\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Imipramine may be confused with amitriptyline, desipramine, Norpramin&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - high [moderate for SIADH]; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F182185\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Reported for tricyclic antidepressants in general.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Arrhythmia, CHF, ECG changes, heart block, hypertension, MI, orthostatic hypotension, palpitation, stroke, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, anxiety, confusion, delusions, disorientation, dizziness, drowsiness, fatigue, hallucination, headache, hypomania, insomnia, nightmares, psychosis, restlessness, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Alopecia, itching, petechiae, photosensitivity, purpura, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Breast enlargement, galactorrhea, gynecomastia, increase or decrease in blood sugar, increase or decrease in libido, SIADH",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramps, anorexia, black tongue, constipation, diarrhea, epigastric disorders, ileus, nausea, stomatitis, taste disturbance, vomiting, weight gain/loss, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Impotence, testicular swelling, urinary retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis, eosinophilia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Cholestatic jaundice, transaminases increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Ataxia, extrapyramidal symptoms, incoordination, numbness, paresthesia, peripheral neuropathy, tingling, tremor, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, disturbances of accommodation, mydriasis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis, falling, hypersensitivity (eg, drug fever, edema)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1053370\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to imipramine (cross-sensitivity with other tricyclics may occur) or any component; use of MAO inhibitors within 14 days (potentially fatal reactions may occur); narrow-angle glaucoma; use during acute recovery phase after MI",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1053354\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with significant renal or hepatic impairment. Use with caution in patients with a history of cardiovascular disease (including previous MI, stroke, tachycardia, or conduction abnormalities); the risk of conduction abnormalities with this agent is high relative to other antidepressants. May cause orthostatic hypotension; risk is very high relative to other antidepressants; use with caution in patients at risk of this effect  or in those who would not tolerate transient hypotensive episodes (eg, cerebrovascular disease, cardiovascular disease, hypovolemia, or concurrent medication use which may predispose to hypotension/bradycardia). Use with caution in patients with respiratory compromise or sleep apnea; use is generally not recommended in patients with severe sleep apnea.  Use with caution in patients at risk of seizures, including those with a history of seizures, head trauma, brain damage, alcoholism, or concurrent therapy with medications which may lower seizure threshold. Use with caution in patients with hyperthyroidism or those receiving thyroid supplementation.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Use of capsules is generally",
"     <b>",
"      not",
"     </b>",
"     recommended in children due to high mg strength and increased potential for acute overdose. Safety of imipramine for long-term chronic use in the treatment of enuresis has not been established; long-term usefulness should be periodically re-evaluated for the individual patient; medication should be tapered off gradually to achieve drug-free period for reassessment; children who relapse with enuresis during drug-free period do not always respond to subsequent courses of therapy.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1053353\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Imipramine is FDA approved for the treatment of nocturnal enuresis in children &ge;6 years of age. Imipramine is not approved for the treatment of depression in pediatric patients. Clinical worsening of depression or suicidal ideation and behavior may occur in children and adults with major depressive disorder",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . In clinical trials, antidepressants increased the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (18-24 years of age) with major depressive disorder and other psychiatric disorders. This risk must be considered before prescribing antidepressants for any clinical use. Short-term studies did",
"     <b>",
"      not",
"     </b>",
"     show an increased risk of suicidality with antidepressant use in patients &gt;24 years of age and showed a decreased risk in patients &ge;65 years.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Patients of all ages who are treated with antidepressants for any indication require appropriate monitoring and close observation for clinical worsening of depression, suicidality, and unusual changes in behavior, especially during the first few months after antidepressant initiation or when the dose is adjusted. Family members and caregivers should be instructed to closely observe the patient (ie, daily) and communicate condition with healthcare provider. Patients should also be monitored for associated behaviors (eg, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania) which may increase the risk for worsening depression or suicidality. Worsening depression or emergence of suicidality (or associated behaviors listed above) that is abrupt in onset, severe, or not part of the presenting symptoms, may require discontinuation or modification of drug therapy.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Do not discontinue abruptly in patients receiving high doses chronically (withdrawal symptoms may occur). To reduce risk of intentional overdose, write prescriptions for the smallest quantity consistent with good patient care. Screen individuals for bipolar disorder prior to treatment (using antidepressants alone may induce manic episodes in patients with this condition). May worsen psychosis in some patients. Imimpramine causes a high degrees of sedation relative to other antidepressants; may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     The American Heart Association recommends that all children diagnosed with ADHD who may be candidates for medication, such as imipramine, should have a thorough cardiovascular assessment prior to initiation of therapy. These recommendations are based upon reports of serious cardiovascular adverse events (including sudden death) in patients (both children and adults) taking usual doses of stimulant medications. Most of these patients were found to have underlying structural heart disease (eg, hypertrophic obstructive cardiomyopathy). The manufacturer recommends not to exceed a dose of 2.5 mg/kg/day in children; ECG changes (of unknown significance) have been reported in pediatric patients who received twice this amount. This assessment should include a combination of thorough medical history, family history, and physical examination. An ECG is not mandatory but should be considered.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     May  cause anticholinergic effects (constipation, xerostomia, blurred vision, urinary retention); use with caution in patients with decreased gastrointestinal motility, paralytic ileus, urinary retention, BPH, xerostomia, or visual problems. The degree of anticholinergic blockade produced by this agent is high relative to other antidepressants.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F182174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2B6 (minor), CYP2C19 (major), CYP2D6 (major), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2C19 (weak), CYP2D6 (moderate), CYP2E1 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F182110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP2D6 Substrates. Management: Avoid concurrent use of abiraterone with CYP2D6 substrates that have a narrow therapeutic index whenever possible.  When concurrent use is not avoidable, monitor patients closely for signs/symptoms of toxicity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists (Direct-Acting): Tricyclic Antidepressants may enhance the vasopressor effect of Alpha-/Beta-Agonists (Direct-Acting).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dipivefrin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Agonists: Tricyclic Antidepressants may enhance the vasopressor effect of Alpha1-Agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha2-Agonists: Tricyclic Antidepressants may diminish the antihypertensive effect of Alpha2-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Apraclonidine; Brimonidine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Altretamine: May enhance the orthostatic hypotensive effect of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Tricyclic Antidepressants may enhance the stimulatory effect of Amphetamines. Tricyclic Antidepressants may also potentiate the cardiovascular effects of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotics: May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aspirin: Antidepressants (Tricyclic, Tertiary Amine) may enhance the antiplatelet effect of Aspirin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May increase the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta2-Agonists: Tricyclic Antidepressants may enhance the adverse/toxic effect of Beta2-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BuPROPion: May decrease the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May increase the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cimetidine: May decrease the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cinacalcet: May increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cobicistat: May increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Codeine: CYP2D6 Inhibitors (Moderate) may diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inducers (Strong): May increase the metabolism of CYP2C19 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inhibitors (Moderate): May decrease the metabolism of CYP2C19 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inhibitors (Strong): May decrease the metabolism of CYP2C19 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Moderate): May decrease the metabolism of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Strong): May decrease the metabolism of CYP2D6 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Substrates: CYP2D6 Inhibitors (Moderate) may decrease the metabolism of CYP2D6 Substrates.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Tamoxifen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Tricyclic Antidepressants may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dexmethylphenidate: May enhance the adverse/toxic effect of Tricyclic Antidepressants. Dexmethylphenidate may increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Divalproex: May increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DULoxetine: May decrease the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fesoterodine: CYP2D6 Inhibitors may increase serum concentrations of the active metabolite(s) of Fesoterodine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.  Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Tricyclic Antidepressants may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Linezolid: May enhance the serotonergic effect of Tricyclic Antidepressants. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: May enhance the neurotoxic effect of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the serotonergic effect of Tricyclic Antidepressants. This may cause serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylene Blue: Tricyclic Antidepressants may enhance the serotonergic effect of Methylene Blue. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May enhance the adverse/toxic effect of Tricyclic Antidepressants. Methylphenidate may increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: May enhance the adverse/toxic effect of Tricyclic Antidepressants. Management: Seek alternatives to this combination when possible. Monitor patients receiving metoclopramide with tricyclic antidepressants for signs of extrapyramidal symptoms, neuroleptic malignant syndrome, and serotonin syndrome.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: Serotonin Modulators may enhance the adverse/toxic effect of Metoclopramide. This may be manifest as symptoms consistent with serotonin syndrome or neuroleptic malignant syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoprolol: CYP2D6 Inhibitors may increase the serum concentration of Metoprolol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: May enhance the adverse/toxic effect of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying). Management: Though the drugs listed here have uncertain QT-prolonging effects, they all have some possible association with QT prolongation and should generally be avoided when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nebivolol: CYP2D6 Inhibitors (Moderate) may increase the serum concentration of Nebivolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (COX-2 Inhibitor): Antidepressants (Tricyclic, Tertiary Amine) may enhance the antiplatelet effect of NSAID (COX-2 Inhibitor).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (Nonselective): Antidepressants (Tricyclic, Tertiary Amine) may enhance the antiplatelet effect of NSAID (Nonselective).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: May increase the serum concentration of CYP2D6 Inhibitors (Moderate).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: May increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Tricyclic Antidepressants may enhance the QTc-prolonging effect of QuiNIDine. QuiNIDine may increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May decrease the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: May enhance the adverse/toxic effect of other Serotonin Modulators. The development of serotonin syndrome may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Phosphates: Tricyclic Antidepressants may enhance the adverse/toxic effect of Sodium Phosphates. Specifically, the risk of seizure and/or loss of consciousness may be increased in patients with significant sodium phosphate induced fluid/electrolyte abnormalities.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     St Johns Wort: May increase the metabolism of Tricyclic Antidepressants. The risk of serotonin syndrome may theoretically be increased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sulfonylureas: Cyclic Antidepressants may enhance the hypoglycemic effect of Sulfonylureas.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tamoxifen: CYP2D6 Inhibitors (Moderate) may decrease serum concentrations of the active metabolite(s) of Tamoxifen. Specifically, CYP2D6 inhibitors may decrease the metabolic formation of highly potent active metabolites.  Management: Consider alternatives with less of an inhibitory effect on CYP2D6 activity when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Terbinafine (Systemic): May decrease the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thioridazine: CYP2D6 Inhibitors may decrease the metabolism of Thioridazine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     TraMADol: Tricyclic Antidepressants may enhance the neuroexcitatory and/or seizure-potentiating effect of TraMADol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic Acid: May increase the serum concentration of Tricyclic Antidepressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Tricyclic Antidepressants may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: Tricyclic Antidepressants may increase the serum concentration of Yohimbine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1053372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Riboflavin dietary requirements may be increased; food does not alter bioavailability",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F10949669\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies are inconclusive. Congenital abnormalities have been reported in humans; however, a casual relationship has not been established. Due to pregnancy-induced physiologic changes, women who are pregnant may require dose adjustments late in pregnancy to achieve euthymia.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1053360\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Heart rate, ECG, supine and standing blood pressure (especially in children), liver enzymes, CBC, serum drug concentrations. Obtain ECG before initiation of therapy and at appropriate intervals in patients with any evidence of cardiovascular disease and in all patients who will receive doses that are larger than usual. Monitor patient periodically for symptom resolution; monitor for worsening depression, suicidality, and associated behaviors (especially at the beginning of therapy or when doses are increased or decreased).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      ADHD:",
"     </b>",
"     Evaluate patients for cardiac disease prior to initiation of therapy for ADHD with thorough medical history, family history, and physical exam; consider ECG; perform ECG and echocardiogram if findings suggest cardiac disease; promptly conduct cardiac evaluation in patients who develop chest pain, unexplained syncope, or any other symptom of cardiac disease during treatment.",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F1053364\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Therapeutic: Imipramine and desipramine 150-250 ng/mL (SI: 530-890 nmol/L); desipramine 150-300 ng/mL (SI: 560-1125 nmol/L)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Potentially toxic: &gt;300 ng/mL (SI: &gt;1070 nmol/L)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Toxic: &gt;1000 ng/mL (SI: &gt;3570 nmol/L)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1053352\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Mechanism not fully defined. As an antidepressant, imipramine increases the synaptic concentration of serotonin and/or norepinephrine in the CNS by inhibition of their reuptake by the presynaptic neuronal membrane. Mechanism of action in controlling childhood enuresis is thought to be apart from the antidepressant effect.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1053368\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Maximum antidepressant effects usually occur after &ge;2 weeks",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1053369\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Crosses the placenta; distributes into breast milk",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     V",
"     <sub>",
"      d",
"     </sub>",
"     : Children: 14.5 L/kg; Adults: &sim;17 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: &gt;90% (primarily to alpha",
"     <sub>",
"      1",
"     </sub>",
"     acid glycoprotein and lipoproteins; to a lesser extent albumin)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: In the liver by microsomal enzymes to desipramine (active) and other metabolites; significant first-pass effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 20% to 80%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: Adults: Range: 6-18 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mean: Children: 11 hours; Adults: 16-17 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Desipramine (active metabolite): Adults: 22-28 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Within 1-2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: In the urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1053359\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/18/36133?source=see_link\">",
"      see \"Imipramine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Read the patient Medication Guide that you receive with each prescription and refill of imipramine. An increased risk of suicidal thinking and behavior has been reported with the use of antidepressants in children, adolescents, and young adults (18-24 years of age). Notify physician if you feel more depressed, have thoughts of suicide, or become more agitated or irritable. Limit caffeine; avoid alcohol and the herbal medicine St. John's wort; may cause drowsiness and impair ability to perform activities requiring mental alertness or physical coordination; may cause dry mouth. May cause photosensitivity reactions (eg, exposure to sunlight may cause severe sunburn, skin rash, redness, or itching); avoid exposure to sunlight and artificial light sources (sunlamps, tanning booth/bed); wear protective clothing, wide-brimmed hats, sunglasses, and lip sunscreen (SPF &ge;15); use a sunscreen [broad-spectrum sunscreen or physical sunscreen (preferred) or sunblock with SPF &ge;15]; contact physician if reaction occurs.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics/American Heart Association Clarification of Statement on Cardiovascular Evaluation and Monitoring of Children and Adolescents With Heart Disease Receiving Medications for ADHD; available at: file://americanheart.mediaroon.com/index.php?s=43&amp;item=422.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Berde C, Ablin A, Glazer J, et al, &ldquo;American Academy of Pediatrics Report of the Subcommittee on Disease-Related Pain in Childhood Cancer,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1990, 86(5 Pt 2):818-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/5/31831/abstract-text/ 2216644 /pubmed\" id=\" 2216644 \" target=\"_blank\">",
"        2216644",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dopheide JA, \"Recognizing and Treating Depression in Children and Adolescents,\"",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2006, 63(3):233-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/5/31831/abstract-text/16434782/pubmed\" id=\"16434782\" target=\"_blank\">",
"        16434782",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Levy HB, Harper CR, and Weinberg WA, &ldquo;A Practical Approach to Children Failing in School,&rdquo;",
"      <i>",
"       Pediatr Clin North Am",
"      </i>",
"      , 1992, 39(4):895-928.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/5/31831/abstract-text/1635811/pubmed\" id=\"1635811\" target=\"_blank\">",
"        1635811",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vetter VL, Elia J, Erickson C, et al, \"Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2008, 117(18):2407-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/5/31831/abstract-text/18427125/pubmed\" id=\"18427125\" target=\"_blank\">",
"        18427125",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wagner KD, \"Pharmacotherapy for Major Depression in Children and Adolescents,\"",
"      <i>",
"       Prog Neuropsychopharmacol Biol Psychiatry",
"      </i>",
"      , 2005, 29(5):819-26.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/5/31831/abstract-text/15908090/pubmed\" id=\"15908090\" target=\"_blank\">",
"        15908090",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13376 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-9070587B58-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31831=[""].join("\n");
var outline_f31_5_31831=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708918\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182136\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182137\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053361\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053355\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182116\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182101\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874618\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053366\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5978078\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053365\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182188\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182185\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053370\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053354\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053353\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182174\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182110\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053372\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10949669\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053360\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053364\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053352\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053368\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053369\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053359\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13376\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13376|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?40/41/41624?source=related_link\">",
"      Imipramine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/18/36133?source=related_link\">",
"      Imipramine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_5_31832="Osteitis fibrosa";
var content_f31_5_31832=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F63957&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F63957&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Micrograph showing osteitis fibrosa due to severe secondary hyperparathyroidism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 267px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bone biopsy from the iliac crest showing osteitis fibrosa due to severe secondary hyperparathyroidism. Left panel: Goldner Masson trichrome stain shows an increased number of multinucleate osteoclasts at the resorptive surfaces (arrow) and extensive bone marrow fibrosis (as shown by the light blue staining of the marrow) replacing normal marrow elements. The increased resorptive activity results in a thin and scalloped appearance to mineralized trabecular bone (blue). Right panel: Tetracycline labeling reveals a marked increase both in osteoid (orange-red staining) and in new bone formation (two distinct yellow-green bands below the majority of orange-red stained osteoid surfaces).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of L Darryl Quarles, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Micrograph showing normal bone histology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 382px; height: 269px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Histologic appearance of normal bone.",
"    <br>",
"     (Left panel) Goldner Masson trichrome stain shows mineralized lamellar bone in blue and adjacent nonmineralized osteoid in red-brown. Osteoid usually comprises less than 25 percent of bone surfaces. The cellular area between the osseous structures is the marrow space.",
"     <br>",
"      (Right panel) Villanueva-stained section viewed under polarized light following time-spaced tetracycline labeling. Osteoid appears orange, mineralized bone is green, and tetracycline markers appear as luminescent yellow-green bands within bone and beneath osteoid (arrow). The distinct dual bands represent active mineralized bone formation.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Courtesy of L Darryl Quarles, MD.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31832=[""].join("\n");
var outline_f31_5_31832=null;
var title_f31_5_31833="Emergency contraception";
var content_f31_5_31833=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Emergency contraception",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/5/31833/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/5/31833/contributors\">",
"     Mimi Zieman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/5/31833/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/5/31833/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/5/31833/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/5/31833/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/5/31833/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emergency contraception (also known as postcoital contraception and the morning-after pill) refers to the use of drugs or a device as an emergency measure to prevent pregnancy. Women who have had recent unprotected intercourse, including those who have had a failure of another method of contraception, are potential candidates for this intervention. It is intended for occasional or back-up use, not as a primary contraceptive method for routine use. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/24/39306?source=see_link\">",
"     \"Overview of contraception\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Health professionals should inform women about use of emergency contraception and the available options. This discussion should include the advantages and disadvantages of each method, including efficacy and side effects. In addition, males should be aware of emergency contraception as a method of preventing pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed above, candidates for emergency contraception are women who have had recent unprotected intercourse (including sexual assault), or who have had a recent possible failure of another method of contraception. A detailed list of potential indications is shown in the table (",
"    <a class=\"graphic graphic_table graphicRef51098 \" href=\"mobipreview.htm?36/2/36907\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ACCESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emergency contraception utilizing progestin-only pills is available without a prescription for individuals (men or women) age 17 and older; proof of age is required (government issued photo or nonphoto identification) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/1\">",
"     1",
"    </a>",
"    ]. Adolescents 16 years and under still require a prescription; however, some states allow specially trained pharmacists to dispense this type of emergency contraception to these women as long as the pharmacist has a standing agreement with a physician to provide these prescriptions as needed. Limited data suggest adolescents use this type of emergency contraception appropriately and tolerate the drug about as well as adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/2-5\">",
"     2-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinicians should be aware of the potential barriers to access and should encourage women to obtain emergency contraceptives in advance of a need for them [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. In 1973, Congress passed the Church Amendment which allowed health care providers (physicians, nurses, pharmacists, etc) to cite religious grounds for refusing to provide abortion or sterilization services. Over time, refusal clauses have passed in most states and have been extended to include contraception and emergency contraception, assisted reproductive technologies, human embryonic or fetal research, and stem cell research. Ideally, professionals who object to providing such services should forewarn their patients and refer them promptly so that their health is not threatened, or care compromised.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MECHANISM OF ACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct laboratory evidence overwhelmingly supports the hypothesis that oral emergency contraceptives work primarily by delaying ovulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/8-10\">",
"     8-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The primary mechanism of copper intrauterine contraception is to inhibit fertilization. It may also have secondary postfertilization contraceptive effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/19/32058?source=see_link\">",
"     \"Overview of intrauterine contraception\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EFFICACY AND RISK FACTORS FOR FAILURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall risk of pregnancy after an episode of coitus without effective contraception is shown in the table (",
"    <a class=\"graphic graphic_table graphicRef58851 \" href=\"mobipreview.htm?0/33/539\">",
"     table 2",
"    </a>",
"    ). These data represent the rate of pregnancy in a population of young couples in their mid-20s. Although conception is possible on only a few days of the cycle, emergency contraception is offered, when indicated, without regard to timing of the menstrual cycle due to uncertainty in timing of ovulation. Results of efficacy studies need to be interpreted within this context, but have generally found that the copper intrauterine contraception (IUD) is the most effective emergency contraceptive option (failure rate 0.04 to 0.19 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/12\">",
"     12",
"    </a>",
"    ], followed by mid-dose (25 to 50 mg) mifepristone or ulipristal acetate (failure rate approximately 1.4 percent) and then levonorgestrel (failure rate 2 to 3 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Looked at in another way, when used within 72 hours of intercourse it is estimated that the copper IUD prevents over 95 percent of expected pregnancies, ulipristal acetate prevents two-thirds of expected pregnancies, and levonorgestrel prevents around 50 percent of pregnancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A meta-analysis including 3445 women who used",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     ulipristal",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    for emergency contraception found three variables that influenced risk of pregnancy after using emergency contraception: body mass index (BMI), conception probability based on day of cycle, and further intercourse after emergency contraception [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Compared to normal weight or underweight women taking",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"       levonorgestrel",
"      </a>",
"      emergency contraception, obese women (BMI &ge;30",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"       )",
"      </span>",
"      who took levonorgestrel for emergency contraception were at four-fold higher risk of pregnancy (OR 4.41; 95% CI 2.05&ndash;9.44) and overweight women (BMI 25-29.9",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"       )",
"      </span>",
"      were at two-fold higher risk of pregnancy (OR 2.09; 95% CI 0.86&ndash;4.87). In fact, for overweight and obese women, levonorgestrel use was not associated with a significant reduction in pregnancy rate compared with that expected with no medication.",
"      <br/>",
"      <br/>",
"      For",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"       ulipristal",
"      </a>",
"      , obese women were at two-fold higher risk of pregnancy (OR 2.62, 95% CI 0.89&ndash;7.00) and overweight women appeared to have no increase in risk (OR 0.97; 95% CI 0.27&ndash;2.83) compared to normal or underweight women using ulipristal for emergency contraception.",
"      <br/>",
"      <br/>",
"      However, the included trials were not designed to assess the role of body mass index or weight in efficacy of emergency contraception. Confidence limits were wide and there were few women, and very few pregnancies, at BMI",
"      <span class=\"nowrap\">",
"       &gt;35kg/m",
"       <sup>",
"        2",
"       </sup>",
"       .",
"      </span>",
"     </li>",
"     <li>",
"      In women using emergency contraception, there was a four-fold increased risk of pregnancy associated with unprotected intercourse during the period of highest probability of conception (intercourse on the day before ovulation when conception probability is 30 percent) compared with intercourse when the risk of conception was theoretically nil (intercourse five days before ovulation to the first day after ovulation) (pregnancy rate 2.9 versus 1.1 percent; OR 4.42, 95% CI 2.33-8.20).",
"     </li>",
"     <li>",
"      Further acts of unprotected intercourse after using emergency contraception was associated with a four-fold increase in pregnancy compared with women who did not report further intercourse (pregnancy rate 6.4 versus 1.5 percent; OR 4.64, 95% CI 2.22-8.96). &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Systematic reviews have concluded that easier access to emergency contraception led to higher utilization, but did not result in a significant drop in the pregnancy rate of the population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. Some limitations of study design may account for these null findings (eg, low power, inadequate provision of emergency contraceptives after the first or second dose). However, inconsistent use of emergency contraception and overestimation of the efficacy of emergency contraception are other possible explanations. A significant observation is that these data did not show any harm from making emergency contraception readily available or any increase in risky sexual behaviors (eg, unprotected intercourse) or acquisition of sexually transmitted disease. Furthermore, given the proven efficacy of the method, it is reasonable to assume that some unplanned pregnancies were prevented in women who used emergency contraception, thus benefiting these individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     OPTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several options are available for emergency contraception (",
"    <a class=\"graphic graphic_table graphicRef70383 \" href=\"mobipreview.htm?22/17/22811\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. We recommend",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    over estradiol plus levonorgestrel because levonorgestrel alone is more effective, has a lower frequency of side effects (see below), and does not require a prescription. Its advantages over intrauterine contraception are that it can be self-administered, has fewer side effects, and is cheaper. However, intrauterine contraception has the advantages of greater efficacy and ongoing highly effective contraception.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     Ulipristal",
"    </a>",
"    appears to be more effective than hormonal emergency contraception 72 to 120 hours after unprotected intercourse, but is not available without a prescription.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Levonorgestrel",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefits of the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    regimen were best illustrated in a systematic review of randomized and controlled trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/13\">",
"     13",
"    </a>",
"    ]. Levonorgestrel was more effective than the Yuzpe regimen in preventing pregnancy (two trials, RR 0.51, 95% CI 0.31-0.83) and was associated with a lower rate of side effects (nausea RR 0.43, 95% CI 0.39- 0.48; vomiting RR: 0.24, 95% CI 0.18-0.31; headache RR 0.83, 95% CI 0.69-1.00, breast tenderness RR 0.84, 95% CI 0.69-1.01).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ethinyl estradiol plus levonorgestrel (Yuzpe regimen)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial studies of post-coital contraception administered high dose estrogens. In 1974, a low dose regimen using a total dose of ethinyl estradiol (200 mcg) plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    (1 mg) was introduced and subsequently termed the Yuzpe regimen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/22\">",
"     22",
"    </a>",
"    ]. Norgestrel (2 mg) may be substituted for levonorgestrel. Treatment was initiated within 72 hours of unprotected intercourse.",
"   </p>",
"   <p>",
"    As discussed above, a randomized trial found the Yuzpe regimen was less effective and associated with more side effects than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    alone, so it is no longer commonly used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/23\">",
"     23",
"    </a>",
"    ]. Despite these disadvantages, some women may find that estrogen-progestin contraceptive pills are more accessible and more private than levonorgestrel, where the package is only labeled for use as an emergency contraceptive.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Copper intrauterine contraception",
"    </span>",
"    &nbsp;&mdash;&nbsp;Copper intrauterine contraception (IUD) can also be used for emergency contraception [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Advantages of this method are that it provides continuing contraception after the initial event and it is more effective than oral regimens, especially in",
"    <span class=\"nowrap\">",
"     overweight/obese",
"    </span>",
"    women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/13,16\">",
"     13,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one multicenter study including 1013 women requesting emergency contraception, the pregnancy rate with IUD insertion within 120 hours after unprotected intercourse was 0.20 per 100 women [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/25\">",
"       25",
"      </a>",
"      ]. Taking into account the probability of pregnancy on each cycle day, the total number of expected pregnancies was 56.8 while the number of observed pregnancies was 2, thus the overall efficacy of preventing pregnancy was 96.9 percent (98.1 and 92.4 percent in the parous and nulliparous groups, respectively). In addition, 86 percent of parous women and 80 percent of nulliparous women who used an IUD for emergency contraception continued with the IUD for contraception.",
"     </li>",
"     <li>",
"      A prospective cohort study of 1963 women receiving the copper T380 A up to five days after unprotected intercourse reported no pregnancies (ie, it was 100 percent effective) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/24\">",
"       24",
"      </a>",
"      ]. The 12-month probability of continuation was 94 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Intrauterine contraception should be avoided in women known to have current gonorrhea or chlamydial infection because of the increased risk of pelvic inflammatory disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/26\">",
"     26",
"    </a>",
"    ]. However, in the absence of acute cervicitis or other medical contraindications, there is no contraindication to inserting the IUD on the same day that the patient presents for emergency contraception [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/29/34265?source=see_link&amp;anchor=H6#H6\">",
"     \"Insertion and removal of an intrauterine contraceptive device\", section on 'Timing of insertion and pregnancy testing'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/29/34265?source=see_link&amp;anchor=H8#H8\">",
"     \"Insertion and removal of an intrauterine contraceptive device\", section on 'Screening for STDs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A detailed discussion of use of copper intrauterine contraception can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/19/32058?source=see_link&amp;anchor=H4#H4\">",
"     \"Overview of intrauterine contraception\", section on 'TCu380A (copper) IUD'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Antiprogestins",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     Ulipristal",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/45/1753?source=see_link\">",
"     mifepristone",
"    </a>",
"    act as antiprogestins and have similar chemical structures. Both are highly effective for use in emergency contraception, and may be more effective than progestins due to their ability to both delay ovulation and inhibit implantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/29\">",
"     29",
"    </a>",
"    ]. A disadvantage of antiprogestins is that the delay in ovulation results in a delay in subsequent menses, which may provoke anxiety about possible pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/30\">",
"     30",
"    </a>",
"    ]. Randomized trials showed that the next menses after ulipristal emergency contraception occurred at a mean of 2.1 days later than expected while menses occurred 1.2 days earlier than expected in",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    users [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Ulipristal",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     Ulipristal",
"    </a>",
"    is a selective progesterone receptor modulator with primarily antiprogestin activity. It can delay ovulation by as much as five days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/31\">",
"     31",
"    </a>",
"    ]. Importantly, it appears to be effective in the advanced follicular phase, including after LH levels have begun to rise but not peaked, a time when",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    emergency contraception is no longer effective in inhibiting ovulation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/47/8952?source=see_link\">",
"     \"Pharmacology and mechanism of action of progesterone receptor modulators (PRMs)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/16/25866?source=see_link\">",
"     \"Therapeutic use and adverse effects of progesterone receptor antagonists and selective progesterone receptor modulators\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A meta-analysis of two trials of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     ulipristal",
"    </a>",
"    versus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    for emergency contraception found that it was at least or more effective than levonorgestrel at 0 to 24 hours (odds of pregnancy OR 0.35, 95% CI 0.11-0.93), 0 to 72 hours (OR 0.58, 95% CI 0.33-0.99), and 0 to 120 hours (OR 0.55, 95% CI 0.32-0.93) after unprotected sexual intercourse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/14\">",
"     14",
"    </a>",
"    ]. In the meta-analysis, at each time interval, the rate of pregnancy in patients receiving ulipristal ranged from 0.9 to 1.4 percent versus 2.2 to 2.5 percent in patients receiving levonorgestrel; these differences were statistically significant. Only 97 women were given ulipristal between 72 and 120 hours after unprotected intercourse, but it is encouraging that none of them became pregnant. By comparison, 106 women took levonorgestrel in the same time frame and three became pregnant. Because of the relatively small number of women and pregnancies with drug administration at 72 to 120 hours, the superiority of ulipristal in this time frame should not be considered proven. There was no difference in the side effect profile of the two drugs.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     Ulipristal",
"    </a>",
"    is available worldwide for emergency contraception. In the US, it is marketed under the name ella&reg;. It can be used for emergency contraception up to 120 hours after intercourse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Mifepristone",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/45/1753?source=see_link\">",
"     Mifepristone",
"    </a>",
"    , an antiprogestin, is not available for emergency contraception in the United States, but is available for this purpose in some other countries. In randomized trials, administration of 5 to 600 mg of mifepristone (RU-486) was 99 to 100 percent effective for preventing pregnancy, thus it is as, or more, effective than other oral emergency contraceptives [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/30,32-35\">",
"     30,32-35",
"    </a>",
"    ]. The optimum dose has not been determined, but is probably 25 to 50 mg [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/36\">",
"     36",
"    </a>",
"    ]. In most series, mifepristone was associated with a low incidence of side effects.",
"   </p>",
"   <p>",
"    Gestrinone appears to be as effective as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/45/1753?source=see_link\">",
"     mifepristone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Prostaglandin inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drugs of this class (COX-1 and COX-2 inhibitors) appear to interfere with several essential steps in female reproduction (eg, oocyte maturation, ovulation). Use of these drugs for emergency contraception is investigational; we recommend not using them for this indication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Meloxicam",
"    </span>",
"    &nbsp;&mdash;&nbsp;A five day course of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/38/35432?source=see_link\">",
"     meloxicam",
"    </a>",
"    blocked ovulation in adult cynomolgus monkeys [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1842774939\">",
"    <span class=\"h3\">",
"     Celecoxib",
"    </span>",
"    &nbsp;&mdash;&nbsp;A placebo-controlled trial in 11 women reported that daily administration of 400 mg",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/11/40120?source=see_link\">",
"     celecoxib",
"    </a>",
"    appeared to delay the timing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    occurrence of luteal events, suggesting that prostaglandin inhibitors may have potential use for emergency contraception [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/40\">",
"     40",
"    </a>",
"    ]. In another study, administration of celecoxib to nonhuman primates reduced the rate of oocyte nuclear maturation and the success of in vitro fertilization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     ADMINISTRATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1661484419\">",
"    <span class=\"h2\">",
"     Prerequisites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neither physical examination nor any laboratory tests are needed before providing oral hormonal (progestin-based) emergency contraception [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/21\">",
"     21",
"    </a>",
"    ]. The physician should inquire whether the act of intercourse for which the contraception is being requested was consensual. If not, the physical and psychological assessment for sexual assault victims should be initiated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/7/20601?source=see_link\">",
"     \"Evaluation and management of adult sexual assault victims\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A pregnancy test is not necessary before administering emergency contraception, unless pregnancy is suspected because of history, symptoms, or a missed or abnormal last menstrual period. Oral hormonal contraception will not interrupt an established pregnancy and has no known adverse effects on the pregnancy or fetus if administered inadvertently. However, placement of a copper IUD or consumption of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     ulipristal",
"    </a>",
"    could adversely affect an established pregnancy. Pregnancy should be excluded before prescribing ulipristal or placing an IUD. If pregnancy cannot be excluded on the basis of history",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    physical examination, pregnancy testing should be performed. Exclusion of pregnancy does not necessarily require an office visit. The patient&rsquo;s menstrual history can be reviewed by telephone and she can be asked to perform and report the results of a home pregnancy test before a prescription is called to the pharmacy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the Centers for Disease Control and Prevention (CDC) and the World Health Organization's Medical Eligibility Criteria for Contraceptive Use applies contraindications to daily use of hormonal contraceptives in some women based on their medical history, these contraindications do",
"    <strong>",
"     not",
"    </strong>",
"    apply to women seeking emergency contraception (",
"    <a class=\"graphic graphic_table graphicRef79761 \" href=\"mobipreview.htm?30/16/30988\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef82516 \" href=\"mobipreview.htm?3/22/3438\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. In particular, cardiovascular disease, thrombophilic disorders, migraine, liver disease, and breastfeeding are considered conditions where the advantages of using the method generally outweigh the theoretical or proven risks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The medical eligibility guidelines do not include information about",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     ulipristal",
"    </a>",
"    . Contraindications to its use are available in the package insert and UpToDate drug database, and include suspected pregnancy, poorly controlled asthma, and hepatic dysfunction.",
"   </p>",
"   <p>",
"    Contraindications to copper IUD use include severe uterine distortion, active pelvic infection, copper allergy, and suspected pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/19/32058?source=see_link&amp;anchor=H23833362#H23833362\">",
"     \"Overview of intrauterine contraception\", section on 'Candidates for intrauterine contraception'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/19/32058?source=see_link&amp;anchor=H23833369#H23833369\">",
"     \"Overview of intrauterine contraception\", section on 'Contraindications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Timing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emergency contraception is offered, when indicated, without regard to day of the menstrual cycle due to uncertainty in timing of ovulation.",
"   </p>",
"   <p>",
"    Both the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    and estradiol plus levonorgestrel regimens are most effective when given as soon as possible after unprotected intercourse; there is a linear relationship between efficacy and the time from intercourse to treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/23,45\">",
"     23,45",
"    </a>",
"    ]. Although package labeling recommends taking levonorgestrel as soon as possible within 72 hours after unprotected intercourse, both the levonorgestrel and estradiol plus levonorgestrel regimens appear to have efficacy up to 120 hours after intercourse and may be started up to that time if necessary, but patients should be informed that efficacy appears to be reduced compared to earlier administration (0 to 72 hours), and especially at 97 to 120 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/46\">",
"     46",
"    </a>",
"    ]. In one trial, the pregnancy rate after emergency contraception with either of these oral hormonal regimens administered by one, two, or three days after unprotected intercourse was 0.4, 1.2, and 2.7 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An advantage of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     ulipristal",
"    </a>",
"    over hormonal oral agents is that it appears to maintain high efficacy for 120 hours after intercourse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/14\">",
"     14",
"    </a>",
"    ]. It is the only oral emergency contraception licensed for use between 72 and 120 hours.",
"   </p>",
"   <p>",
"    The IUD as an emergency contraceptive is effective up to five days after ovulation because of its post-fertilization effects, but it is nearly impossible to determine the exact day a woman ovulated by history alone, so the window for use as an emergency contraceptive has been simplified to five days after unprotected intercourse. For women who seek emergency contraception more than five days after unprotected intercourse, insertion of a copper intrauterine contraceptive may still be effective because of secondary postfertilization mechanisms of contraception [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/11,47\">",
"     11,47",
"    </a>",
"    ], but data are limited. In a systematic review of the efficacy of the IUD for emergency contraception, only three of the 42 studies had a maximum time for insertion of the IUD as long as 7 days; none of the 492 patients in these three studies became pregnant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Agent and dose",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Levonorgestrel",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     Levonorgestrel",
"    </a>",
"    is available in the United States as Plan B One-Step&trade;, a single dose emergency contraceptive containing levonorgestrel 1.5 mg in a single tablet, and as Next Choice&trade; pill packs that contain two 0.75 mg tablets to be taken 12 hours apart. In the United Kingdom, levonorgestrel for emergency contraception is available as Levonelle&trade; 1500, which consists of one 1.5 mg tablet.",
"   </p>",
"   <p>",
"    We recommend the single dose regimen for all women. The single dose regimen is more convenient than the split dose regimen and randomized trials have shown that it is as effective as a split dose, without increasing the frequency of side effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/13,32,48,49\">",
"     13,32,48,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some experts suggest avoiding a single dose regimen in women who may not achieve adequate hormone levels, such as those taking liver enzyme-inducing anticonvulsant drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. This recommendation was based on clinical judgment, taking into consideration the consequences of an unintended pregnancy. We do not suggest a split dose regimen to any subset of women.",
"   </p>",
"   <p>",
"    If a split dose regimen is planned, the interval between the two doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    can be lengthened to 24 hours apart without significantly changing efficacy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/48,52\">",
"     48,52",
"    </a>",
"    ]. A longer interval is particularly convenient for women who take the first dose in the afternoon. Another potential advantage of the 24-hour interval is that the efficacy of the 12-hour regimen declined significantly when there were further acts of intercourse after treatment (after one and multiple coital events, the pregnancy rate was 1 versus 5 percent, respectively); however, this decline in efficacy was not observed in the 24-hour interval group.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Estradiol plus levonorgestrel",
"    </span>",
"    &nbsp;&mdash;&nbsp;No estrogen-progestin oral contraceptive is available in pill packets specifically intended for emergency contraception; however, the patient can be instructed to take multiple oral contraceptive pills from packets designed for cyclic use to approximate the dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    recommended for emergency contraception (1 mg).",
"   </p>",
"   <p>",
"    The efficacy of combined pills containing progestin hormones other than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    has not been well evaluated for use as emergency contraception, so we recommend not using them for this purpose.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Ulipristal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Where available,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     ulipristal",
"    </a>",
"    is marketed as a 30 mg tablet under the brand name ella&trade; or ellaOne&trade;.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Copper intrauterine contraception",
"    </span>",
"    &nbsp;&mdash;&nbsp;The device must be inserted within five days of ovulation; this recommendation is often simplified to five days after unprotected intercourse. It can be removed after a woman's next menstrual period or left in place for up to 10 years as a continual birth control system.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     Levonorgestrel",
"    </a>",
"    -releasing IUDs have not been studied for this indication.",
"   </p>",
"   <p>",
"    Intrauterine contraception is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/19/32058?source=see_link\">",
"     \"Overview of intrauterine contraception\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/29/34265?source=see_link\">",
"     \"Insertion and removal of an intrauterine contraceptive device\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;No deaths or serious complications have been associated with emergency contraception [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nausea and vomiting are the most common side effects of the oral hormonal drugs, and are more common with estrogen-progestin regimens than the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    -only regimen (nausea 43 versus 18 percent; vomiting 16 and 4 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/21\">",
"     21",
"    </a>",
"    ]. Side effects for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     ulipristal",
"    </a>",
"    are similar to those for levonorgestrel [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Irregular bleeding is not uncommon in the month after treatment, and has been reported in 16 percent of patients in the first week after use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/32,53\">",
"     32,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Uncommon side effects include dizziness, fatigue, headache, breast tenderness, and lower abdominal pain. These may be treated symptomatically, as needed.",
"   </p>",
"   <p>",
"    Insertion of copper intrauterine contraception can cause discomfort. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/29/34265?source=see_link\">",
"     \"Insertion and removal of an intrauterine contraceptive device\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Prevention of nausea and vomiting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antiemetics can be given to reduce nausea and vomiting. They should be given prophylactically with estrogen-progestin regimens, given the high incidence of side effects, but may be provided as needed with the better tolerated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    regimen.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/17/37141?source=see_link\">",
"     Meclizine",
"    </a>",
"    50 mg, taken one hour before the first dose of estrogen-progestin, reduces nausea and vomiting, but can cause some sedation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/54\">",
"     54",
"    </a>",
"    ]. A randomized study comparing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    (10 mg) and placebo taken one hour before each estrogen-progestin dose found metoclopramide significantly reduced the frequency of nausea from 56 to 28 percent; the reduction in vomiting was of borderline statistical significance, 22 versus 11 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     If emergency contraceptives are vomited",
"    </span>",
"    &nbsp;&mdash;&nbsp;If",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    is vomited within two hours of administration and no antiemetic was given, we suggest giving an antiemetic agent and then repeating the levonorgestrel.",
"   </p>",
"   <p>",
"    If estrogen-progestin pills are vomited within one hour of ingestion and an antiemetic was not taken prophylactically, then an antiemetic can be given and the estrogen-progestin dose repeated. Alternatively,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    alone can be administered for emergency contraception.",
"   </p>",
"   <p>",
"    If vomiting occurs within three hours of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     ulipristal",
"    </a>",
"    <strong>",
"    </strong>",
"    intake, we suggest giving an antiemetic and then repeating the dose; however, this will require a second prescription. One option is to write for one refill with each prescription so the patient has access to more medication if she vomits.",
"   </p>",
"   <p>",
"    There is some evidence that vaginal administration of emergency contraceptives (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    , Yuzpe regimen) may also be effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/56-58\">",
"     56-58",
"    </a>",
"    ]. However, the efficacy of this approach has not been thoroughly investigated and the optimal dose is controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/56-58\">",
"     56-58",
"    </a>",
"    ]. We would consider it only as a last resort if premedication with antiemetics was ineffective or use of a copper intrauterine device was unacceptable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8357332\">",
"    <span class=\"h2\">",
"     Drug interactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drugs that induce liver enzymes have the potential to decrease the contraceptive efficacy of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     ulipristal",
"    </a>",
"    . A guideline from the Royal College of Obstetricians and Gynaecologists recommends that women on liver enzyme-inducing drugs or who have stopped using them within 28 days and require emergency contraception be offered a copper IUD, as its efficacy is not affected by these drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/59\">",
"     59",
"    </a>",
"    ]. For women who are ineligible or who do not want to use an IUD, they suggest a single 3 mg dose of levonorgestrel, although there is no evidence to support this approach.",
"   </p>",
"   <p>",
"    Experts recommend that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     ulipristal",
"    </a>",
"    acetate be avoided in women using enzyme-inducing drugs or who have taken them within the last 28 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/60\">",
"     60",
"    </a>",
"    ]. Women should also be advised to avoid ulipristal if they are currently taking drugs that increase gastric pH (eg, antacids, histamine H2 antagonists and proton pump inhibitors).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Need for additional contraception",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duration of effectiveness of emergency contraception has not been determined, thus it is not clear when regular contraception should be resumed or initiated within the menstrual cycle of emergency contraceptive use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/61\">",
"     61",
"    </a>",
"    ]. The safest approach is to advise women using emergency contraception pills that a risk of pregnancy still exists if they have unprotected sexual intercourse after the pills have been taken; therefore, they should immediately initiate an effective contraceptive method.",
"   </p>",
"   <p>",
"    Based on expert opinion and pharmacokinetic studies, barrier or hormonal methods (pill, patch, ring) can be",
"    <span class=\"nowrap\">",
"     initiated/resumed",
"    </span>",
"    the day after the last emergency contraception pill has been taken (hormonal methods require a back-up method for the first seven days of use). Although efficacy is not compromised by immediate initiation, it is prudent to avoid starting longer-acting hormonal methods (eg, depot-",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/1/35863?source=see_link\">",
"     etonogestrel",
"    </a>",
"    implant,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    -releasing intrauterine devices) until it is certain that pregnancy has not occurred. However, this concern should be balanced against risk of unintended pregnancy if initiation of one of these methods is delayed.",
"   </p>",
"   <p>",
"    For women who took",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     ulipristal",
"    </a>",
"    for emergency contraception, there is theoretical concern that starting a hormonal method after taking ulipristal could make either the ulipristal or the hormonal method less effective by competitive binding to the progestin receptors. The ulipristal package insert recommends using a barrier method for the remainder of the cycle. Some experts advise waiting seven days after ulipristal to start a hormonal method. One guideline recommends that additional precautions be taken for 14 days after taking ulipristal (9 days if using or starting the progestogen-only pill, 16 days for estradiol",
"    <span class=\"nowrap\">",
"     valerate/",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?26/46/27366?source=see_link\">",
"      dienogest",
"     </a>",
"    </span>",
"    pill) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2789045\">",
"    <span class=\"h2\">",
"     Additional doses of emergency contraception",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no contraindication to giving a second dose of hormonal emergency contraception if a second episode of unprotected intercourse occurs anytime after the first dose was administered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no support for use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"     ulipristal",
"    </a>",
"    more than once per cycle or if there has been another episode of unprotected sexual intercourse outside the treatment window (&gt;120 hours) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Follow-up",
"    </span>",
"    &nbsp;&mdash;&nbsp;A routine follow-up office visit is not required [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/21\">",
"     21",
"    </a>",
"    ]. With any form of emergency contraception, a pregnancy test should be performed to exclude the possibility of an intrauterine or ectopic pregnancy if bleeding has not occurred within three to four weeks or if there is abdominal pain or irregular bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/21,64\">",
"     21,64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Menstrual bleeding after emergency contraception typically occurs within one week of the expected time. The time to menses resumption after treatment is similar for progestin-only and estrogen-progestin regimens. If the single dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    -only regimen is taken within the first three weeks of the cycle, the next menses will be earlier than usual; the magnitude of this effect is greatest when the pills are taken early in the cycle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/65\">",
"     65",
"    </a>",
"    ]. If taken late in the cycle, the next menses will be prolonged. Cycle length then returns to baseline.",
"   </p>",
"   <p>",
"    Data on the outcome of pregnancy after failure of emergency contraception are sparse. A systematic review found no evidence of an increase in risk of ectopic pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/66\">",
"     66",
"    </a>",
"    ]. There is also no evidence of teratogenic effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/13,21,67,68\">",
"     13,21,67,68",
"    </a>",
"    ], which is not surprising given that combination hormonal contraceptives when inadvertently taken early in pregnancy have not been associated with teratogenic effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Advance provision",
"    </span>",
"    &nbsp;&mdash;&nbsp;A significant proportion of pregnancies worldwide are unintended. This is due to both inconsistent use of regular contraception and underutilization of emergency contraception (see",
"    <a class=\"local\" href=\"#H5\">",
"     'Efficacy and risk factors for failure'",
"    </a>",
"    above) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. We suggest that women using barrier, or other contraception, have a home supply of emergency contraceptives in addition to their primary mode of contraception. As an example, women taking oral contraceptives may run out of their pills or women using depot",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    may be late returning for their injections. Teenagers under age 17 should be given a prescription for emergency contraception (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    ) and counseled about its use so they can access it readily if needed in the future [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/5/31833/abstract/71\">",
"     71",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/28/12738?source=see_link\">",
"       \"Patient information: Emergency contraception (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/32/24068?source=see_link\">",
"       \"Patient information: Emergency contraception (morning after pill) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Candidates for emergency contraception are women who have had recent unprotected intercourse (including sexual assault), or those who have had a failure of another method of contraception (eg, broken condoms, late for their depot-medroxyprogesterone injections). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are no medical contraindications to use of oral emergency contraception. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Contraindications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neither a physical examination nor laboratory testing is needed before prescribing",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"       levonorgestrel",
"      </a>",
"      or an estrogen-progestin regimen for emergency contraception. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Administration'",
"      </a>",
"      above.) Pregnancy should be excluded and, if not conclusively excluded by history, pregnancy testing should be performed, particularly before prescribing",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"       ulipristal",
"      </a>",
"      or intrauterine contraception. (See",
"      <a class=\"local\" href=\"#H1661484419\">",
"       'Prerequisites'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest administering emergency contraception as soon as possible, but up to 120 hours, after an episode of unprotected intercourse in women who wish to prevent pregnancy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Given the uncertainty in timing of ovulation, emergency contraception is offered, when indicated, without regard to day of the menstrual cycle. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Timing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest the copper intrauterine contraceptive device (IUD) for emergency contraception (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). It is more effective than oral emergency contraceptives, its effectiveness is not reduced in overweight and obese women, and it provides ongoing pregnancy prevention. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Copper intrauterine contraception'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women who wish to avoid use of an IUD, we recommend",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/31/39412?source=see_link\">",
"       ulipristal",
"      </a>",
"      over",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"       levonorgestrel",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Ulipristal is effective any time within 120 hours of unprotected intercourse. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Options'",
"      </a>",
"      above.) For obese women, however, ulipristal may be less effective or not effective. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Efficacy and risk factors for failure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women who choose hormonal emergency contraception, we recommend",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"       levonorgestrel",
"      </a>",
"      rather than an estrogen-progestin regimen (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Levonorgestrel is more effective and has fewer side effects. We suggest a single dose of levonorgestrel 1.5 mg for most women (",
"      <a class=\"grade\" href=\"._grade_4?title=Grade 2A\">",
"       Grade 2A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Options'",
"      </a>",
"      above.) It is most effective if given within 72 hours of unprotected intercourse. For overweight or obese women, levonorgestrel may be less effective or not effective. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Efficacy and risk factors for failure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A routine follow-up office visit is not required after taking emergency contraception. Menstrual bleeding after oral hormonal emergency contraception typically occurs within one week of the expected time. A pregnancy test should be performed if bleeding has not occurred within three to four weeks or if there is persistent vaginal bleeding or abdominal pain. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Follow-up'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women using emergency contraception pills should be advised that a risk of pregnancy still exists if they have unprotected sexual intercourse after emergency contraception pills have been taken. A repeat course of emergency contraception can be given, but it is preferable that they begin regular use of nonemergency contraception, which can be initiated the day after emergency contraception administration. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Need for additional contraception'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest giving women a home supply of emergency contraceptives or encouraging them to buy them in advance (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Women 16 and under can be given a prescription for emergency contraception in advance. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Advance provision'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     www.fda.gov. (Accessed on June 06, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/2\">",
"      Harper CC, Rocca CH, Darney PD, et al. Tolerability of levonorgestrel emergency contraception in adolescents. Am J Obstet Gynecol 2004; 191:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/3\">",
"      Raine T, Harper C, Leon K, Darney P. Emergency contraception: advance provision in a young, high-risk clinic population. Obstet Gynecol 2000; 96:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/4\">",
"      Gold MA, Wolford JE, Smith KA, Parker AM. The effects of advance provision of emergency contraception on adolescent women's sexual and contraceptive behaviors. J Pediatr Adolesc Gynecol 2004; 17:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/5\">",
"      Harper CC, Cheong M, Rocca CH, et al. The effect of increased access to emergency contraception among young adolescents. Obstet Gynecol 2005; 106:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/6\">",
"      Harrison T. Availability of emergency contraception: a survey of hospital emergency department staff. Ann Emerg Med 2005; 46:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/7\">",
"      Amey AL, Bishai D. Measuring the quality of medical care for women who experience sexual assault with data from the National Hospital Ambulatory Medical Care Survey. Ann Emerg Med 2002; 39:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/8\">",
"      Trussell J, Guthrie KA. Talking straight about emergency contraception. J Fam Plann Reprod Health Care 2007; 33:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/9\">",
"      Gemzell-Danielsson K. Mechanism of action of emergency contraception. Contraception 2010; 82:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/10\">",
"      No&eacute; G, Croxatto HB, Salvatierra AM, et al. Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation. Contraception 2011; 84:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/11\">",
"      Stanford JB, Mikolajczyk RT. Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects. Am J Obstet Gynecol 2002; 187:1699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/12\">",
"      Cleland K, Zhu H, Goldstuck N, et al. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod 2012; 27:1994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/13\">",
"      Cheng L, G&uuml;lmezoglu AM, Piaggio G, et al. Interventions for emergency contraception. Cochrane Database Syst Rev 2008; :CD001324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/14\">",
"      Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet 2010; 375:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/15\">",
"      Glasier A. Emergency contraception: clinical outcomes. Contraception 2013; 87:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/16\">",
"      Glasier A, Cameron ST, Blithe D, et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception 2011; 84:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/17\">",
"      Raymond EG, Trussell J, Polis CB. Population effect of increased access to emergency contraceptive pills: a systematic review. Obstet Gynecol 2007; 109:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/18\">",
"      Polis CB, Schaffer K, Blanchard K, et al. Advance provision of emergency contraception for pregnancy prevention (full review). Cochrane Database Syst Rev 2007; :CD005497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/19\">",
"      Polis CB, Schaffer K, Blanchard K, et al. Advance provision of emergency contraception for pregnancy prevention: a meta-analysis. Obstet Gynecol 2007; 110:1379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/20\">",
"      Food and Drug Administration. Prescription drug products: Certain combined oral contraceptives for use as emergency postcoital contraception. Fed Regist 1997; 62:8610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/21\">",
"      American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 112: Emergency contraception. Obstet Gynecol 2010; 115:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/22\">",
"      Yuzpe AA, Thurlow HJ, Ramzy I, Leyshon JI. Post coital contraception--A pilot study. J Reprod Med 1974; 13:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/23\">",
"      Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation. Lancet 1998; 352:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/24\">",
"      Wu S, Godfrey EM, Wojdyla D, et al. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG 2010; 117:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/25\">",
"      Zhou L, Xiao B. Emergency contraception with Multiload Cu-375 SL IUD: a multicenter clinical trial. Contraception 2001; 64:107.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report (MMWR). U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. Adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition. Early release - May 28, 2010. file://www.cdc.gov/mmwr/preview/mmwrhtml/rr59e0528a1.htm (Accessed on May 28, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/27\">",
"      Harper CC, Speidel JJ, Drey EA, et al. Copper intrauterine device for emergency contraception: clinical practice among contraceptive providers. Obstet Gynecol 2012; 119:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/28\">",
"      Schwarz EB, Kavanaugh M, Douglas E, et al. Interest in intrauterine contraception among seekers of emergency contraception and pregnancy testing. Obstet Gynecol 2009; 113:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/29\">",
"      Glasier A. Emergency postcoital contraception. N Engl J Med 1997; 337:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/30\">",
"      Glasier A, Thong KJ, Dewar M, et al. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. N Engl J Med 1992; 327:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/31\">",
"      Brache V, Cochon L, Jesam C, et al. Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture. Hum Reprod 2010; 25:2256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/32\">",
"      von Hertzen H, Piaggio G, Ding J, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002; 360:1803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/33\">",
"      Webb AM, Russell J, Elstein M. Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception. BMJ 1992; 305:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/34\">",
"      Comparison of three single doses of mifepristone as emergency contraception: a randomised trial. Task Force on Postovulatory Methods of Fertility Regulation. Lancet 1999; 353:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/35\">",
"      Hamoda H, Ashok PW, Stalder C, et al. A randomized trial of mifepristone (10 mg) and levonorgestrel for emergency contraception. Obstet Gynecol 2004; 104:1307.",
"     </a>",
"    </li>",
"    <li>",
"     Mittal S. Interventions for emergency contraception: RHL commentary (last revised: 1 November 2008). The WHO Reproductive Health Library; Geneva: World Health Organization.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/37\">",
"      Wu S, Dong J, Cong J, et al. Gestrinone compared with mifepristone for emergency contraception: a randomized controlled trial. Obstet Gynecol 2010; 115:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/38\">",
"      Hester KE, Harper MJ, Duffy DM. Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primates when administered to simulate emergency contraception. Hum Reprod 2010; 25:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/39\">",
"      Jesam C, Salvatierra AM, Schwartz JL, Croxatto HB. Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception. Hum Reprod 2010; 25:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/40\">",
"      Edelman AB, Jensen JT, Hennebold JD. A nonhormonal model for emergency contraception: prostaglandin synthesis inhibitor effects on luteal function and lifespan, a pilot study. Contraception 2010; 81:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/41\">",
"      Duffy DM, VandeVoort CA. Maturation and fertilization of nonhuman primate oocytes are compromised by oral administration of a cyclooxygenase-2 inhibitor. Fertil Steril 2011; 95:1256.",
"     </a>",
"    </li>",
"    <li>",
"     www.who.int/reproductive-health/publications/mec/. (Accessed December 6, 2005).",
"    </li>",
"    <li>",
"     CDC. U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. Classification for emergency contraception. file://www.cdc.gov/mmwr/pdf/rr/rr59e0528.pdf (Accessed on October 12, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/44\">",
"      van Rooijen M, Silveira A, Thomassen S, et al. Rapid activation of haemostasis after hormonal emergency contraception. Thromb Haemost 2007; 97:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/45\">",
"      Piaggio G, von Hertzen H, Grimes DA, Van Look PF. Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Task Force on Postovulatory Methods of Fertility Regulation. Lancet 1999; 353:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/46\">",
"      Piaggio G, Kapp N, von Hertzen H. Effect on pregnancy rates of the delay in the administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trials. Contraception 2011; 84:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/47\">",
"      Trussell, J, Ellertson, C. Efficacy of emergency contraception. Fertil Control Rev 1995; 4:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/48\">",
"      Hansen LB, Saseen JJ, Teal SB. Levonorgestrel-only dosing strategies for emergency contraception. Pharmacotherapy 2007; 27:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/49\">",
"      Arowojolu AO, Okewole IA, Adekunle AO. Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians. Contraception 2002; 66:269.",
"     </a>",
"    </li>",
"    <li>",
"     www.ffprhc.org.uk/admin/uploads/534_Levonelle1500KeyStatment.pdf. (Accessed October 13, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/51\">",
"      Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC Guidance (April 2006). Emergency contraception. J Fam Plann Reprod Health Care 2006; 32:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/52\">",
"      Ngai SW, Fan S, Li S, et al. A randomized trial to compare 24 h versus 12 h double dose regimen of levonorgestrel for emergency contraception. Hum Reprod 2005; 20:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/53\">",
"      Webb A, Shochet T, Bigrigg A, et al. Effect of hormonal emergency contraception on bleeding patterns. Contraception 2004; 69:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/54\">",
"      Raymond EG, Creinin MD, Barnhart KT, et al. Meclizine for prevention of nausea associated with use of emergency contraceptive pills: a randomized trial. Obstet Gynecol 2000; 95:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/55\">",
"      Ragan RE, Rock RW, Buck HW. Metoclopramide pretreatment attenuates emergency contraceptive-associated nausea. Am J Obstet Gynecol 2003; 188:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/56\">",
"      Devoto L, Fuentes A, Palomino A, et al. Pharmacokinetics and endometrial tissue levels of levonorgestrel after administration of a single 1.5-mg dose by the oral and vaginal route. Fertil Steril 2005; 84:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/57\">",
"      Mor E, Saadat P, Kives S, et al. Comparison of vaginal and oral administration of emergency contraception. Fertil Steril 2005; 84:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/58\">",
"      Kives S, Hahn PM, White E, et al. Bioavailability of the Yuzpe and levonorgestrel regimens of emergency contraception: vaginal vs. oral administration. Contraception 2005; 71:197.",
"     </a>",
"    </li>",
"    <li>",
"     Faculty of Sexual and Reproductive Healthcare Clinical Guidance. Emergency contraception. January 2012. www.fsrh.org/pdfs/CEUguidanceEmergencyContraception11.pdf (Accessed on January 26, 2012).",
"    </li>",
"    <li>",
"     Clinical Effectiveness Unit. Drug interactions with hormonal contraception. London (UK): Faculty of Sexual and Reproductive Healthcare; 2012 Jan. 26 file://guideline.gov/content.aspx?f=rss&amp;id=36072 (Accessed on June 25, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/61\">",
"      Salcedo J, Rodriguez MI, Curtis KM, Kapp N. When can a woman resume or initiate contraception after taking emergency contraceptive pills? A systematic review. Contraception 2012.",
"     </a>",
"    </li>",
"    <li>",
"     Clinical Effectiveness Unit. Combined hormonal contraception. London (UK): Faculty of Sexual and Reproductive Healthcare; 2011 Oct. 28 file://guideline.gov/content.aspx?f=rss&amp;id=36071 (Accessed on June 25, 2012).",
"    </li>",
"    <li>",
"     Contraceptive Technology Update 2004; 25:57.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/64\">",
"      Wertheimer RE. Emergency postcoital contraception. Am Fam Physician 2000; 62:2287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/65\">",
"      Raymond EG, Goldberg A, Trussell J, et al. Bleeding patterns after use of levonorgestrel emergency contraceptive pills. Contraception 2006; 73:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/66\">",
"      Cleland K, Raymond E, Trussell J, et al. Ectopic pregnancy and emergency contraceptive pills: a systematic review. Obstet Gynecol 2010; 115:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/67\">",
"      De Santis M, Cavaliere AF, Straface G, et al. Failure of the emergency contraceptive levonorgestrel and the risk of adverse effects in pregnancy and on fetal development: an observational cohort study. Fertil Steril 2005; 84:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/68\">",
"      Zhang L, Chen J, Wang Y, et al. Pregnancy outcome after levonorgestrel-only emergency contraception failure: a prospective cohort study. Hum Reprod 2009; 24:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/69\">",
"      Lakha F, Glasier A. Unintended pregnancy and use of emergency contraception among a large cohort of women attending for antenatal care or abortion in Scotland. Lancet 2006; 368:1782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/70\">",
"      Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006; 38:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/5/31833/abstract/71\">",
"      American Academy of Pediatrics. Policy statement: Emergency contraception. Pediatrics 2012; 130:1174.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5475 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-190.92.87.115-0E8DCFA2F5-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31833=[""].join("\n");
var outline_f31_5_31833=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ACCESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MECHANISM OF ACTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EFFICACY AND RISK FACTORS FOR FAILURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      OPTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Levonorgestrel",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ethinyl estradiol plus levonorgestrel (Yuzpe regimen)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Copper intrauterine contraception",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Antiprogestins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Ulipristal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Mifepristone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Prostaglandin inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Meloxicam",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1842774939\">",
"      - Celecoxib",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      ADMINISTRATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1661484419\">",
"      Prerequisites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Timing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Agent and dose",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Levonorgestrel",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Estradiol plus levonorgestrel",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Ulipristal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Copper intrauterine contraception",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Side effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Prevention of nausea and vomiting",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - If emergency contraceptives are vomited",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8357332\">",
"      Drug interactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Need for additional contraception",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2789045\">",
"      Additional doses of emergency contraception",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Follow-up",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Advance provision",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/5475\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5475|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?36/2/36907\" title=\"table 1\">",
"      Potential indications for using emergency contraception",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/33/539\" title=\"table 2\">",
"      Probability of pregnancy after unprotected intercourse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/17/22811\" title=\"table 3\">",
"      Options for emergency contraception",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/16/30988\" title=\"table 4\">",
"      WHO emergency contraception",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/22/3438\" title=\"table 5\">",
"      CDC guideline for emergency contraception",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/7/20601?source=related_link\">",
"      Evaluation and management of adult sexual assault victims",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/29/34265?source=related_link\">",
"      Insertion and removal of an intrauterine contraceptive device",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/24/39306?source=related_link\">",
"      Overview of contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/19/32058?source=related_link\">",
"      Overview of intrauterine contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/28/12738?source=related_link\">",
"      Patient information: Emergency contraception (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?23/32/24068?source=related_link\">",
"      Patient information: Emergency contraception (morning after pill) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/47/8952?source=related_link\">",
"      Pharmacology and mechanism of action of progesterone receptor modulators (PRMs)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/16/25866?source=related_link\">",
"      Therapeutic use and adverse effects of progesterone receptor antagonists and selective progesterone receptor modulators",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_5_31834="Ichthyosis vulgaris 2";
var content_f31_5_31834=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F61258%7EPEDS%2F66723%7EPEDS%2F59842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F61258%7EPEDS%2F66723%7EPEDS%2F59842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ichthyosis vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 291px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Skin with fine, white, adherent scale is present in this patient with ichthyosis vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart HP. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    X-linked ichthyosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    X-linked ichthyosis: legs, infant.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Stedman's Medical Dictionary. Copyright &copy;2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lamellar ichthyosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 297px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lamellar ichthyosis: abdomen, child.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Stedman's Medical Dictionary. Copyright &copy;2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31834=[""].join("\n");
var outline_f31_5_31834=null;
var title_f31_5_31835="Causes primary hypogonadism";
var content_f31_5_31835=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F53842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F53842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of primary hypogonadism in males",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Congenital abnormalities",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Klinefelter syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Other chromosomal abnormalities",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Mutation in the FSH and LH receptor genes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cryptorchidism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Varicocele",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Disorders of androgen synthesis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Myotonic dystrophy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Acquired diseases",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Infections, especially mumps",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Radiation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Alkylating agents",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Suramin",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ketoconazole",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Glucocorticoids",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Environmental toxins",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Trauma",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Testicular torsion",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Autoimmune damage",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Chronic systemic illnesses",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Hepatic cirrhosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Chronic renal failure",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       AIDS",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Idiopathic",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31835=[""].join("\n");
var outline_f31_5_31835=null;
var title_f31_5_31836="BRCA2 mutations male breast CA";
var content_f31_5_31836=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F80912&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F80912&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    BRCA2 mutations in male breast cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Author; year",
"       </td>",
"       <td class=\"subtitle1\">",
"        Men tested",
"       </td>",
"       <td class=\"subtitle1\">",
"        Men with BRCA2 mutations",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent of men with BRCA2 mutations",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent of men with positive family history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Couch, FJ; 1996",
"       </td>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thorlacius, S; 1996",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        25",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Friedman, LS; 1997",
"       </td>",
"       <td>",
"        54",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        17",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mavraki, E; 1997",
"       </td>",
"       <td>",
"        28",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        36",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Haraldsson, K; 1998",
"       </td>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        21",
"       </td>",
"       <td>",
"        13",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Csokay, B; 1999",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diez, O; 2000",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        53",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sverdlov, R; 2000",
"       </td>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        35",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kwiatkowska, E; 2001",
"       </td>",
"       <td>",
"        37",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        13",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Basham, V; 2002",
"       </td>",
"       <td>",
"        94",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Frank, TS; 2002",
"       </td>",
"       <td>",
"        76",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        36",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ottini, L; 2003",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        28",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ding, Y; 2011",
"       </td>",
"       <td>",
"        115",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        22",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31836=[""].join("\n");
var outline_f31_5_31836=null;
var title_f31_5_31837="Cyclic incidence of GCA";
var content_f31_5_31837=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F77458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F77458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cyclic incidence of giant cell arteritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 250px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Annual incidence rates of giant cell arteritis in Olmsted County, Minnesota, per 100,000 people who are 50 years of age or older. The rates were calculated using a centered three-year moving average. A cyclic incidence is present, with peaks occurring every five to seven years.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Salvarani Cl, Gabriel SE, O'Fallon WM, et al. Ann Intern Med 1995; 123:192.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31837=[""].join("\n");
var outline_f31_5_31837=null;
var title_f31_5_31838="TADS CDRSR results";
var content_f31_5_31838=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F51677&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F51677&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Adjusted mean scores on the Children's Depression Rating Scale-Revised for participants in the Treatment for Adolescents with Depression Study",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 326px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Treatment for Adolescents with Depression Study (TADS) Team. Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents with Depression: Treatment for Adolescents with Depression Study (TADS) Randomized Controlled Trial. JAMA 2004; 292:807.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31838=[""].join("\n");
var outline_f31_5_31838=null;
var title_f31_5_31839="Fluorosc stent placement";
var content_f31_5_31839=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F68706&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F68706&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    EUS-guided pancreatic pseudocyst drainage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 372px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fluoroscopic image demonstrating insertion of a stent introduction catheter into the pseudocyst over the previously placed guidewire following balloon dilatation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kenneth E Fasanella, MD, and Michael K Sanders, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_5_31839=[""].join("\n");
var outline_f31_5_31839=null;
